alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,051–5,075 of 7,816 matching trials · page 203 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Trial of the C-TraC Intervention for Dementia Patients
NCT02388711
C-TraC Intervention
Runs in: United States · 1 site 		NA
other		 COMPLETED 584 University of Wisconsin, Madison
OTHER		 2021-02-12
A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
NCT03197740
Donepezil patch; aricept Tab
Runs in: South Korea · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 399 Icure Pharmaceutical Inc.
INDUSTRY		 2021-02-11
Driving in Mild Dementia Decision Tool
NCT02036099
Driving in Mild Dementia Decision Tool
Runs in: Canada · 1 site 		NA
other		 COMPLETED 69 Sunnybrook Health Sciences Centre
OTHER		 2021-02-10
Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
NCT03448055
Immunocal
Runs in: Canada · 1 site 		NA
other		 UNKNOWN 25 Immunotec Inc.
INDUSTRY		 2021-02-10
Cognitive Dysfunction in Parkinson's Disease
NCT02346708
Real TMS; Sham TMS
Runs in: United States · 1 site 		NA
other		 COMPLETED 49 University of Colorado, Denver
OTHER		 2021-02-09
Repetitive TMS of the Default Mode Network in AD
NCT03778151
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION
Runs in: Italy · 2 sites 		NA
other		 COMPLETED 50 I.R.C.C.S. Fondazione Santa Lucia
OTHER		 2021-02-08
Experiences and Attitudes Towards Agitated Behaviours in TBI ICU Patients: a Protocol for an Interprofessional Mixed-method Study
NCT04741399 		NA
other		 UNKNOWN 98 Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
OTHER		 2021-02-05
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
NCT02521558
Intervention Group; Control Group
Runs in: United States · 1 site 		NA
other		 TERMINATED 30 Boston University
OTHER		 2021-02-04
Detecting an Early Response to Donepezil With Measures of Visual Attention
NCT03073876
Donepezil Hydrochloride; Placebo
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 25 NYU Langone Health
OTHER		 2021-02-04
Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults
NCT04262674
Cognitive-motor training
Runs in: Switzerland · 1 site 		NA
other		 UNKNOWN 82 Empa, Swiss Federal Laboratories for Materials Science and Technology
OTHER		 2021-02-04
Effects of a Dementia-friendly Program
NCT04737733
The dementia friendly program
Runs in: Norway · 1 site 		NA
other		 COMPLETED 423 University Hospital, Akershus
OTHER		 2021-02-04
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease
NCT02956486
Elenbecestat; Placebo
Runs in: Argentina; Australia; Austria; Bulgaria; Canada; Czechia;... · 258 sites 		PHASE3
BACE-inhibitor		 TERMINATED 2,212 Eisai Co., Ltd.
INDUSTRY		 2021-02-03
Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia
NCT02210286
Magtein
Runs in: United States · 1 site 		NA
other		 COMPLETED 17 Stanford University
OTHER		 2021-02-02
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease
NCT03612622
transcranial magnetic stimulation
Runs in: China · 1 site 		NA
other		 COMPLETED 47 Anhui Medical University
OTHER		 2021-02-02
Powerful Tools for Caregivers of Dementia Patients
NCT02697721
Powerful Tools for Caregivers; Control with delayed intervention
Runs in: United States · 1 site 		NA
other		 COMPLETED 60 Florida State University
OTHER		 2021-01-29
A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease
NCT03520998
GRF6019
Runs in: United States · 10 sites 		PHASE2
other		 COMPLETED 47 Alkahest, Inc.
INDUSTRY		 2021-01-29
Rehabilitation of Facial Emotion Recognition in Alzheimer's Disease
NCT04730440
AD-TAR; AD-Cognitive Stimulation 		NA
other		 COMPLETED 8 Centre Hospitalier Princesse Grace
OTHER		 2021-01-29
Biomarker Study for Alzheimer's Disease
NCT02472899
Blood sample
Runs in: Israel · 1 site 		NA
other		 COMPLETED 115 Beersheva Mental Health Center
OTHER_GOV		 2021-01-27
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )
NCT02686216
F-18 THK-5351 		PHASE1
other		 COMPLETED 24 Chang Gung Memorial Hospital
OTHER		 2021-01-27
A Study to Assess the Safety of GRF6019 Infusions in Subjects With Severe Alzheimer's Disease
NCT03765762
GRF6019; Placebo
Runs in: United States · 6 sites 		PHASE2
other		 COMPLETED 26 Alkahest, Inc.
INDUSTRY		 2021-01-27
Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects
NCT04169126
F-18 PMPBB3
Runs in: Taiwan · 1 site 		PHASE2
other		 UNKNOWN 300 Chang Gung Memorial Hospital
OTHER		 2021-01-27
Using fMRI-guided TMS to Increase Central Executive Function in Older Adults (MCI_Sub)
NCT04176406
rTMS; Sham rTMS
Runs in: United States · 1 site 		NA
other		 TERMINATED 10 Duke University
OTHER		 2021-01-27
Effects of Multimodal Training of Combined Cognitive and/or Physical Training on Cognition and Fitness of Older Adults
NCT04727450
Cognitive training; physical training; Combination of cognitive and...
Runs in: Hong Kong · 1 site 		NA
other		 UNKNOWN 228 Hong Kong Baptist University
OTHER		 2021-01-27
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
NCT00467818
Omega 3 fatty acids; Placebo
Runs in: United States · 1 site 		NA
other		 COMPLETED 17 University of Medicine and Dentistry of New Jersey
OTHER		 2021-01-26
An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311
NCT03531710
UB-311; Placebo
Runs in: Taiwan · 4 sites 		PHASE2
other		 TERMINATED 34 United Neuroscience Ltd.
INDUSTRY		 2021-01-26

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →